共 50 条
Phosphorylation of amyloid precursor protein (APP) at Thr668 regulates the nuclear translocation of the APP intracellular domain and induces neurodegeneration
被引:149
|作者:
Chang, Keun-A
Kim, Hye-Sun
Ha, Tae-Young
Ha, Ji-Won
Shin, Ki Young
Jeong, Yun Ha
Lee, Jean-Pyo
Park, Cheol-Hyoung
Kim, Seonghan
Baik, Tae-Kyoung
Suh, Yoo-Hun
[1
]
机构:
[1] Seoul Natl Univ, Dept Pharmacol, Coll Med, Creat Res Initiat Ctr Alzheimers Dementia,MRC, Seoul 110799, South Korea
[2] Seoul Natl Univ, MRC, Neurosci Res Inst, Seoul 110799, South Korea
[3] Eulji Univ, Coll Med, Dept Anat, Taejon 301832, South Korea
[4] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA
关键词:
D O I:
10.1128/MCB.02393-05
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
Amyloid precursor protein (APP) has eight potential phosphorylation sites in its cytoplasmic domain. Recently, it has demonstrated that the constitutive phosphorylation of APP at T668 (APP695 isoform numbering) was observed specifically in the brain. Neuron-specific phosphorylation of APP at T668 is thought to be important for neuronal functions of APP, although its exact physiological significance remains to be clarified. In this study, we show that the phosphorylation of the APP intracellular domain (AICD) at T668 is essential for its binding to Fe65 and its nuclear translocation and affects the resultant neurotoxicity, possibly mediated through the induction of glycogen synthase kinase 3 beta and tau phosphorylation by enhancing the formation of a ternary complex with Fe65 and CP2 transcription factor. Taken together, these results suggest that the phosphorylation of AICD at T668 contributes to the neuronal degeneration in Alzheimer's disease (AD) by regulating its translocation into the nucleus and then affects neurodegeneration; therefore, the specific inhibitor of T668 phosphorylation might be the target of AD therapy.
引用
收藏
页码:4327 / 4338
页数:12
相关论文